Abstract
JMIR AI is a new journal with a focus on publishing applied artificial intelligence and machine learning research. This editorial provides an overview of the primary objectives, the focus areas of the journal, and the types of articles that are within scope.
The Translation Gap in Clinical AI
Despite a decade of explosive growth in artificial intelligence and machine learning (AI/ML) methodology for biomedicine, a frustrating paradox has emerged: the actual impact on clinical practice remains surprisingly thin. This "translation gap" became particularly evident during the COVID-19 pandemic. While there was a surge in publications, AI-driven diagnostic and prognostic tools largely failed to significantly accelerate the global response.
The gap is fueled by several systemic challenges:
- Data Quality and Representation: Models frequently fail when applied to real-world populations that were not adequately represented in the training datasets.
- The Trust Deficit: There remains a significant lack of trust in automated decision-making among both clinicians and patients.
- Regulatory Hurdles: The emergence of new policies, such as the EU Artificial Intelligence Act, has created a complex landscape for researchers attempting to move algorithms from "bench to bedside."
A New Venue for Applied Research
JMIR AI has been launched as a peer-reviewed, open-access journal specifically designed to address these practical issues. Rather than focusing solely on incremental improvements in algorithmic accuracy, the journal prioritizes research that explores how models survive and function within clinical environments.
Multidisciplinary Oversight and Scope
To ensure that published research is grounded in real-world constraints, JMIR AI utilizes an editorial board comprising experts from academia, the pharmaceutical industry, and the medical device sector. The journal's scope extends beyond technical papers to include articles on:
- Ethics, law, and policy.
- Regulatory issues and compliance.
- Implementation science in healthcare settings.
- Benchmark datasets and validated code.
Infrastructure for Reproducibility
A core mission of JMIR AI is to facilitate "open science" in a field where technical and regulatory obstacles often make it difficult. The journal intends to provide authors with tools to streamline code and data sharing. By establishing benchmark datasets as a primary article type, the journal aims to provide the "fit-for-use" data necessary for developing generalizable models.
Regulation as a Catalyst
Rather than viewing new AI statutes as a burden, the editorial vision sees these policies as a catalyst for progress. Regulation will redefine standards for algorithmic explainability, continuous model evaluation, and data transparency. By bridging the gap between industry, academia, and spin-off health technology companies, JMIR AI seeks to foster a robust community capable of navigating these commercial and regulatory complexities.
Conclusion
The success of clinical AI depends on solving socio-technical problems—such as data access and the trust deficit—which are often more stubborn than mathematical ones. As the field continues its rapid advancement, JMIR AI will evolve its scope and tools to help researchers navigate the path toward meaningful clinical impact.
Summary updated